Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 593-598

  Ganguli, Subhas C ^a   Park, Chan Guk ^a   Holtmann, Martin H ^a   Hadac, Elizabeth M ^a   Kenakin, Terry P ^b   Miller, Laurence J ^a  

^a MAYO CLINIC   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE DERIVATIVE; PARATHYROID HORMONE RECEPTOR; PERTUSSIS TOXIN; RECEPTOR; SECRETIN; SECRETIN DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN COS1; CONCENTRATION RESPONSE; CONTROLLED STUDY; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BINDING, COMPETITIVE; COS CELLS; CYCLIC AMP; GTP-BINDING PROTEINS; GUANYLYL IMIDODIPHOSPHATE; MOLECULAR CONFORMATION; MUTAGENESIS; PERTUSSIS TOXIN; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; SIGNAL TRANSDUCTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0032410647     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Abou Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT, Kronenberg HM and Segre GV (1992)Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732-2736.
2. Aquino CJ, Armour DR, Berman JM, Birkemo LS, Carr RAE, Croom DK, Dezube M, Dougherty RW, JR, Ervin GN, Grizzle MK, Head JE, Hirst GC, James MK, Johnson MF, Miller LJ, Queen KL, Rimele TJ, Smith DN and Sugg EE (1996) Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "Trigger." J Med Chem 39:562-569.
3. Cao Y-J, Gimpl G and Fahrenholz F (1995) The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. Biochem Biophys Res Commun 212:673-680.
4. 2+/inositol phosphate signaling pathways. Mol Endocrinol 6:551-556.
5. Costa T and Herz A (1989) Antagonists with negative intrinsic activity at opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86:7321-7325.
6. Delean A, Stadel JM and Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255:7108-7117.
7. Grigorieff N, Ceska TA, Downing KH, Baldwin JM and Henderson R (1996) EIectron-crystallographic refinement of the structure of bacteriorhodopsin. J Mol Biol 259:393-421.
8. Holtmann MH, Hadac EM and Miller LJ (1995) Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J Biol Chem 270:14394-14398.
9. Holtmann MH, Ganguli S, Hadac EM, Dolu V and Miller LJ (1996) Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem 271:14944-14949.
10. Jüppner H, Schipani E, Bringhurst FE, Mcclure I, Keutmann HT, Potts JT, JR, Kronenberg HM, Abou-Samra A. B, Segre GV and Gardella TJ (1994) The extracellular amino-terminal region of the parathyroid hormone (PTH.)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). Endocrinology 134:879-884.
11. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharm Rev 48:413-463.
12. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG and Lefkowitz RJ (1992) Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267:1430-1433.
13. Kosugi S, Mori T and Shenker A (1996) The role of Asp578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J Biol Chem 271:31813-31817.
14. Kunkel TA (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection Proc Natl Acad Sci USA 82:488-492.
15. Laburthe M, Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C and Nicole P (1996) Receptors for VIP, PACAP, secretin, GRF, glucagon GLP-1 and other members of their new family of G protein-linked receptors: Structure-function relationship with special reference to the human VIP-1 receptor. Ann NY Acad Sci 805:94-111.
16. Latronico AC, Anasti J, Arnhold IJP, Mendonca BB, Domenice S, Albano MC, Zachman K, Wajchenberg BL and Tsigos C (1995) A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 80:2490-2494.
17. Lefkowitz RJ, Cotecchia S, Samama P and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
18. Lopata MA, Cleveland DW and Sollner-Webb B (1984) High level transient expression of a chloramphenicol acetyl transferee gene by DEA.E-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. Nucleic Acids Res 12:5707-5717.
19. Munson PJ and Rodbard D (1980) LIGAND a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
20. Parma J, Duprez L, Vansande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651.
21. 2-adrenergic receptor. J Biol Chem 268:16483-16487.
22. Robinson PR, Cohen GB, Zhukovsky EA and Oprian DD (1992) Constitutively active mutants of rhodopsin. Neuron 9:719-725.
23. 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636.
24. Sanger F, Nicklen S and Coulson AR (1977) Dna sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
25. Schipani E, Kruse K and Jüppner H (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100.
26. Schipani E, Langman CB, Parfitt AM, Jensen GS, Kikuchi S, Kooh SW, Cole WG and Juppner H (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondroplasia. N Engl J Med 335:708-714.
27. Trimble ER, Bruzzone R, Biden TJ, Meehan CJ, Andreu D and Merrifield RB (1987) Secretin stimulates cyclic Amp and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. Proc Natl Acad Sci USA 84:3146-3150.
28. Ulrich CD, II, Pinon DI, Hadac EM, Holicky EL, Chang-Miller A, Gates LK and Miller LJ (1993) Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. Gastroenterology 105:1534-1543.
29. Unger VM and Schertler GFX (1995) Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. Biophys J 68:1776-1786.
30. Vilardaga J-P, De Neef P, Di Paolo E, Bollen A, Waelbroeck M and Robberecht P (1995) Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. Biochem Biophys Res Commun 211:885-891.
31. Weiss JM, Morgan PH, Lutz MW and Kenakin TP (1996a) The cubic ternary complex receptor-occupancy model. I. Model description. J Theor Biol 178:151-167.
32. Weiss JM, Morgan PH, Lutz MW and Kenakin TP (1996b) The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity. J Theor Biol 178: 169-182.